NRx Pharmaceuticals, Inc. (NRXP) Discusses Regulatory Update and Development Pipeline Expansion for Preservative-Free Ketamine Formulation Transcript

Core Points - NRx Pharmaceuticals, Inc. is conducting a corporate update call to discuss recent developments and future plans [1] - The call includes forward-looking statements that are subject to risks and uncertainties, which may lead to actual results differing from expectations [2][3] - Dr. Jonathan Javitt, the Founder, Chairman, and CEO, will provide a regulatory update and discuss a significant addition to the company's development pipeline [4]